Skip to main content

PATRONES DE EXPRESION EN COMORBILIDAD INVERSA

BFU2015-71241-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2015
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Dirección General de Investigación Científica y Técnica
Beneficiary centre FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Intronic CNVs and gene expression variation in human populations

  • Rigau, Maria
  • Juan Sopeña, David Alejandro, 1975-
  • Valencia, Alfonso
  • Rico, Daniel
Introns can be extraordinarily large and they account for the majority of the DNA sequence in human genes. However, little is known about their population patterns of structural variation and their functional implication. By combining the most extensive maps of CNVs in human populations, we have found that intronic losses are the most frequent copy number variants (CNVs) in protein-coding genes in human, with 12,986 intronic deletions, affecting 4,147 genes (including 1,154 essential genes and 1,638 disease-related genes). This intronic length variation results in dozens of genes showing extreme population variability in size, with 40 genes with 10 or more different sizes and up to 150 allelic sizes. Intronic losses are frequent in evolutionarily ancient genes that are highly conserved at the protein sequence level. This result contrasts with losses overlapping exons, which are observed less often than expected by chance and almost exclusively affect primate-specific genes. An integrated analysis of CNVs and RNA-seq data showed that intronic loss can be associated with significant differences in gene expression levels in the population (CNV-eQTLs). These intronic CNV-eQTLs regions are enriched for intronic enhancers and can be associated with expression differences of other genes showing long distance intron-promoter 3D interactions. Our data suggests that intronic structural variation of protein-coding genes makes an important contribution to the variability of gene expression and splicing in human populations., This work was supported by Project Retos BFU2015-71241-R Spanish Ministry of Economy, Industry and Competitiveness (MEIC, http://www.mineco.gob.es), co-funded by European Regional Development Fund (ERDF) to A.V. and Wellcome Trust (https://wellcome.ac.uk) Seed Award in Science (206103/Z/17/Z) to D.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Automatic identification of informative regions with epigenomic changes associated to hematopoiesis

  • Carrillo-de-Santa Pau, Enrique
  • Juan, David
  • Pancaldi, Vera
  • Were, Felipe
  • Martin-Subero, José Ignacio
  • Rico, Daniel
  • Valencia, Alfonso
  • BLUEPRINT Consortium
Includes supplementary material for the online appendix., Hematopoiesis is one of the best characterized biological systems but the connection between chromatin changes and lineage differentiation is not yet well understood. We have developed a bioinformatic workflow to generate a chromatin space that allows to classify 42 human healthy blood epigenomes from the BLUEPRINT, NIH ROADMAP and ENCODE consortia by their cell type. This approach let us to distinguish different cells types based on their epigenomic profiles, thus recapitulating important aspects of human hematopoiesis. The analysis of the orthogonal dimension of the chromatin space identify 32,662 chromatin determinant regions (CDRs), genomic regions with different epigenetic characteristics between the cell types. Functional analysis revealed that these regions are linked with cell identities. The inclusion of leukemia epigenomes in the healthy hematological chromatin sample space gives us insights on the healthy cell types that are more epigenetically similar to the disease samples. Further analysis of tumoral epigenetic alterations in hematopoietic CDRs points to sets of genes that are tightly regulated in leukemic transformations and commonly mutated in other tumors. Our method provides an analytical approach to study the relationship between epigenomic changes and cell lineage differentiation. Method availability: https://github.com/david-juan/ChromDet., European Union’s Seventh Framework Programme [FP7/2007–2013, 282510 (BLUEPRINT)]; Spanish Ministry of Economy, Industry and Competitiveness and European Regional Development Fund [Project Retos BFU2015–71241-R]. Funding for open access charge: Project Retos BFU2015–71241-R (to A.V.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Intronic CNVs and gene expression variation in human populations

  • Rigau, Maria
  • Juan, David
  • Valencia, Alfonso
  • Rico, Daniel
Introns can be extraordinarily large and they account for the majority of the DNA sequence in human genes. However, little is known about their population patterns of structural variation and their functional implication. By combining the most extensive maps of CNVs in human populations, we have found that intronic losses are the most frequent copy number variants (CNVs) in protein-coding genes in human, with 12,986 intronic deletions, affecting 4,147 genes (including 1,154 essential genes and 1,638 disease-related genes). This intronic length variation results in dozens of genes showing extreme population variability in size, with 40 genes with 10 or more different sizes and up to 150 allelic sizes. Intronic losses are frequent in evolutionarily ancient genes that are highly conserved at the protein sequence level. This result contrasts with losses overlapping exons, which are observed less often than expected by chance and almost exclusively affect primate-specific genes. An integrated analysis of CNVs and RNA-seq data showed that intronic loss can be associated with significant differences in gene expression levels in the population (CNV-eQTLs). These intronic CNV-eQTLs regions are enriched for intronic enhancers and can be associated with expression differences of other genes showing long distance intron-promoter 3D interactions. Our data suggests that intronic structural variation of protein-coding genes makes an important contribution to the variability of gene expression and splicing in human populations., This work was supported by Project Retos BFU2015-71241-R Spanish Ministry of Economy, Industry and Competitiveness (MEIC, http://www.mineco.gob.es), co-funded by European Regional Development Fund (ERDF) to A.V. and Wellcome Trust (https://wellcome.ac.uk) Seed Award in Science (206103/Z/17/Z) to D.R.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Interpreting molecular similarity between patients as a determinant of disease comorbidity relationships

  • Sánchez-Valle, Jon
  • Tejero-Cicuéndez, Héctor
  • Fernández, José María
  • Juan, David
  • Urda-García, Beatriz
  • Capella-Gutiérrez, Salvador
  • Al-Shahrour, Fátima
  • Tabarés-Seisdedos, Rafael
  • Baudot, Anaïs
  • Pancaldi, Vera
  • Valencia, Alfonso
Comorbidity is a medical condition attracting increasing attention in healthcare and biomedical research. Little is known about the involvement of potential molecular factors leading to the emergence of a specific disease in patients affected by other conditions. We present here a disease interaction network inferred from similarities between patients’ molecular profiles, which significantly recapitulates epidemiologically documented comorbidities. Furthermore, we identify disease patient-subgroups that present different molecular similarities with other diseases, some of them opposing the general tendencies observed at the disease level. Analyzing the generated patient-subgroup network, we identify genes involved in such relations, together with drugs whose effects are potentially associated with the observed comorbidities. All the obtained associations are available at the disease PERCEPTION portal (http://disease-perception.bsc.es)., This work was supported by a Ph.D. Fellowship (BES-2016-077403) and funded by the Spanish Ministry of Economics and Competitiveness (BFU2015-71241-R, RTI2018-096653-B-I00). The Coordination Node led by A.V. at the Barcelona Supercomputing Center (BSC) is a member of the Spanish National Bioinformatics Institute (INB), ISCIII-Bioinformatics platform and is supported by grant PT17/0009/0001 of the Acción Estratégica en Salud 2013-2016 of the Programa Estatal de Investigación Orientada a los Retos de la Sociedad, funded by the Instituto de Salud Carlos III (ISCIII) and European Regional Development Fund (ERDF). V.P. is supported by INSERM, the Fondation Toulouse Cancer Santé and Pierre Fabre Research Institute as part of the Chair of Bioinformatics in Oncology of the CRCT. A.B. has received funding from the Excellence Initiative of Aix-Marseille University—A*Midex, a French “Investissements d’Avenir” program. D.J. was supported by Juan de la Cierva fellowship (FJCI-2016-29558) from the Ministerio de Ciencia, Innovación y Universidades. H.T. and F.A.-S. were supported by the Instituto de Salud Carlos III (ISCIII), Spanish National Bioinformatic
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

ChiPPI: a novel method for mapping chimeric protein–protein interactions uncovers selection principles of protein fusion events in cancer

  • Frenkel-Morgenstern, Milana
  • Gorohovski, Alessandro
  • Tagore, Somnath
  • Sekar, Vaishnovi
  • Vazquez, Miguel
  • Valencia, Alfonso|||0000-0002-8937-6789
Fusion proteins, comprising peptides deriving from the translation of two parental genes, are produced in cancer by chromosomal aberrations. The expressed fusion protein incorporates domains of both parental proteins. Using a methodology that treats discrete protein domains as binding sites for specific domains of interacting proteins, we have cataloged the protein interaction networks for 11 528 cancer fusions (ChiTaRS-3.1). Here, we present our novel method, chimeric protein–protein interactions (ChiPPI) that uses the domain–domain co-occurrence scores in order to identify preserved interactors of chimeric proteins. Mapping the influence of fusion proteins on cell metabolism and pathways reveals that ChiPPI networks often lose tumor suppressor proteins and gain oncoproteins. Furthermore, fusions often induce novel connections between non-interactors skewing interaction networks and signaling pathways. We compared fusion protein PPI networks in leukemia/lymphoma, sarcoma and solid tumors finding distinct enrichment patterns for each disease type. While certain pathways are enriched in all three diseases (Wnt, Notch and TGF β), there are distinct patterns for leukemia (EGFR signaling, DNA replication and CCKR signaling), for sarcoma (p53 pathway and CCKR signaling) and solid tumors (FGFR and EGFR signaling). Thus, the ChiPPI method represents a comprehensive tool for studying the anomaly of skewed cellular networks produced by fusion proteins in cancer., This work is funded by the Project Retos BFU2015-71241-R of the Spanish Ministry of Economy, Industry and Competitiveness (MEIC), co-funded by European Regional Development Fund (ERDF) and by the Project PT13/0001/0030, Instituto de Salud Carlos III (ISCIII), Strategic Action in Health, co-funded by European Regional Development Fund (ERDF). The work of MFM is supported by the Israel Cancer Association (ICA) fund, the work of ST is supported by the VaTaT Postdoctoral Fellowship for excellent students [22351, 20027, 26912]. AV is supported by the Joint BSC-CRG-IRB Programme in Computational Biology. Funding for open access charge: ICA [e-cancer-diagnosis]., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Automatic identification of informative regions with epigenomic changes associated to hematopoiesis

  • Carrillo-de-Santa-Pau, Enrique
  • Juan, David
  • Pancaldi, Vera|||0000-0002-7433-624X
  • Were, Felipe
  • Martin-Subero, Ignacio
  • Rico, Daniel
  • Valencia, Alfonso|||0000-0002-8937-6789
Hematopoiesis is one of the best characterized biological systems but the connection between chromatin changes and lineage differentiation is not yet well understood. We have developed a bioinformatic workflow to generate a chromatin space that allows to classify 42 human healthy blood epigenomes from the BLUEPRINT, NIH ROADMAP and ENCODE consortia by their cell type. This approach let us to distinguish different cells types based on their epigenomic profiles, thus recapitulating important aspects of human hematopoiesis. The analysis of the orthogonal dimension of the chromatin space identify 32,662 chromatin determinant regions (CDRs), genomic regions with different epigenetic characteristics between the cell types. Functional analysis revealed that these regions are linked with cell identities. The inclusion of leukemia epigenomes in the healthy hematological chromatin sample space gives us insights on the healthy cell types that are more epigenetically similar to the disease samples. Further analysis of tumoral epigenetic alterations in hematopoietic CDRs points to sets of genes that are tightly regulated in leukemic transformations and commonly mutated in other tumors. Our method provides an analytical approach to study the relationship between epigenomic changes and cell lineage differentiation. Method availability: https://github.com/david-juan/ChromDet., European Union’s Seventh Framework Programme [FP7/2007–2013, 282510 (BLUEPRINT)]; Spanish Ministry of Economy, Industry and Competitiveness and European Regional Development Fund [Project Retos BFU2015–71241-R]. Funding for open access charge: Project Retos BFU2015–71241-R (to A.V.)., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

ChiPPI: a novel method for mapping chimeric protein–protein interactions uncovers selection principles of protein fusion events in cancer

  • Frenkel-Morgenstern, Milana
  • Gorohovski, Alessandro
  • Tagore, Somnath
  • Sekar, Vaishnovi
  • Vazquez, Miguel
  • Valencia, Alfonso
Fusion proteins, comprising peptides deriving from the translation of two parental genes, are produced in cancer by chromosomal aberrations. The expressed fusion protein incorporates domains of both parental proteins. Using a methodology that treats discrete protein domains as binding sites for specific domains of interacting proteins, we have cataloged the protein interaction networks for 11 528 cancer fusions (ChiTaRS-3.1). Here, we present our novel method, chimeric protein–protein interactions (ChiPPI) that uses the domain–domain co-occurrence scores in order to identify preserved interactors of chimeric proteins. Mapping the influence of fusion proteins on cell metabolism and pathways reveals that ChiPPI networks often lose tumor suppressor proteins and gain oncoproteins. Furthermore, fusions often induce novel connections between non-interactors skewing interaction networks and signaling pathways. We compared fusion protein PPI networks in leukemia/lymphoma, sarcoma and solid tumors finding distinct enrichment patterns for each disease type. While certain pathways are enriched in all three diseases (Wnt, Notch and TGF β), there are distinct patterns for leukemia (EGFR signaling, DNA replication and CCKR signaling), for sarcoma (p53 pathway and CCKR signaling) and solid tumors (FGFR and EGFR signaling). Thus, the ChiPPI method represents a comprehensive tool for studying the anomaly of skewed cellular networks produced by fusion proteins in cancer., This work is funded by the Project Retos BFU2015-71241-R of the Spanish Ministry of Economy, Industry and Competitiveness (MEIC), co-funded by European Regional Development Fund (ERDF) and by the Project PT13/0001/0030, Instituto de Salud Carlos III (ISCIII), Strategic Action in Health, co-funded by European Regional Development Fund (ERDF). The work of MFM is supported by the Israel Cancer Association (ICA) fund, the work of ST is supported by the VaTaT Postdoctoral Fellowship for excellent students [22351, 20027, 26912]. AV is supported by the Joint BSC-CRG-IRB Programme in Computational Biology. Funding for open access charge: ICA [e-cancer-diagnosis]., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Intronic CNVs and gene expression variation in human populations

  • Rigau, Maria
  • Juan Sopeña, David Alejandro, 1975-
  • Valencia, Alfonso
  • Rico, Daniel
Introns can be extraordinarily large and they account for the majority of the DNA sequence in human genes. However, little is known about their population patterns of structural variation and their functional implication. By combining the most extensive maps of CNVs in human populations, we have found that intronic losses are the most frequent copy number variants (CNVs) in protein-coding genes in human, with 12,986 intronic deletions, affecting 4,147 genes (including 1,154 essential genes and 1,638 disease-related genes). This intronic length variation results in dozens of genes showing extreme population variability in size, with 40 genes with 10 or more different sizes and up to 150 allelic sizes. Intronic losses are frequent in evolutionarily ancient genes that are highly conserved at the protein sequence level. This result contrasts with losses overlapping exons, which are observed less often than expected by chance and almost exclusively affect primate-specific genes. An integrated analysis of CNVs and RNA-seq data showed that intronic loss can be associated with significant differences in gene expression levels in the population (CNV-eQTLs). These intronic CNV-eQTLs regions are enriched for intronic enhancers and can be associated with expression differences of other genes showing long distance intron-promoter 3D interactions. Our data suggests that intronic structural variation of protein-coding genes makes an important contribution to the variability of gene expression and splicing in human populations., This work was supported by Project Retos BFU2015-71241-R Spanish Ministry of Economy, Industry and Competitiveness (MEIC, http://www.mineco.gob.es), co-funded by European Regional Development Fund (ERDF) to A.V. and Wellcome Trust (https://wellcome.ac.uk) Seed Award in Science (206103/Z/17/Z) to D.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Automatic identification of informative regions with epigenomic changes associated to hematopoiesis

  • Carrillo-de-Santa Pau, Enrique
  • Juan, David
  • Pancaldi, Vera
  • Were, Felipe
  • Martin-Subero, José Ignacio
  • Rico, Daniel
  • Valencia, Alfonso
  • BLUEPRINT Consortium
Includes supplementary material for the online appendix., Hematopoiesis is one of the best characterized biological systems but the connection between chromatin changes and lineage differentiation is not yet well understood. We have developed a bioinformatic workflow to generate a chromatin space that allows to classify 42 human healthy blood epigenomes from the BLUEPRINT, NIH ROADMAP and ENCODE consortia by their cell type. This approach let us to distinguish different cells types based on their epigenomic profiles, thus recapitulating important aspects of human hematopoiesis. The analysis of the orthogonal dimension of the chromatin space identify 32,662 chromatin determinant regions (CDRs), genomic regions with different epigenetic characteristics between the cell types. Functional analysis revealed that these regions are linked with cell identities. The inclusion of leukemia epigenomes in the healthy hematological chromatin sample space gives us insights on the healthy cell types that are more epigenetically similar to the disease samples. Further analysis of tumoral epigenetic alterations in hematopoietic CDRs points to sets of genes that are tightly regulated in leukemic transformations and commonly mutated in other tumors. Our method provides an analytical approach to study the relationship between epigenomic changes and cell lineage differentiation. Method availability: https://github.com/david-juan/ChromDet., European Union’s Seventh Framework Programme [FP7/2007–2013, 282510 (BLUEPRINT)]; Spanish Ministry of Economy, Industry and Competitiveness and European Regional Development Fund [Project Retos BFU2015–71241-R]. Funding for open access charge: Project Retos BFU2015–71241-R (to A.V.).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Automatic identification of informative regions with epigenomic changes associated to hematopoiesis

  • Carrillo-de-Santa-Pau, Enrique
  • Juan, David
  • Pancaldi, Vera
  • Were, Felipe
  • Martin-Subero, Ignacio
  • Rico, Daniel
  • Valencia, Alfonso
Hematopoiesis is one of the best characterized biological systems but the connection between chromatin changes and lineage differentiation is not yet well understood. We have developed a bioinformatic workflow to generate a chromatin space that allows to classify 42 human healthy blood epigenomes from the BLUEPRINT, NIH ROADMAP and ENCODE consortia by their cell type. This approach let us to distinguish different cells types based on their epigenomic profiles, thus recapitulating important aspects of human hematopoiesis. The analysis of the orthogonal dimension of the chromatin space identify 32,662 chromatin determinant regions (CDRs), genomic regions with different epigenetic characteristics between the cell types. Functional analysis revealed that these regions are linked with cell identities. The inclusion of leukemia epigenomes in the healthy hematological chromatin sample space gives us insights on the healthy cell types that are more epigenetically similar to the disease samples. Further analysis of tumoral epigenetic alterations in hematopoietic CDRs points to sets of genes that are tightly regulated in leukemic transformations and commonly mutated in other tumors. Our method provides an analytical approach to study the relationship between epigenomic changes and cell lineage differentiation. Method availability: https://github.com/david-juan/ChromDet., European Union’s Seventh Framework Programme [FP7/2007–2013, 282510 (BLUEPRINT)]; Spanish Ministry of Economy, Industry and Competitiveness and European Regional Development Fund [Project Retos BFU2015–71241-R]. Funding for open access charge: Project Retos BFU2015–71241-R (to A.V.)., Peer Reviewed, Postprint (published version)